Back to Results
First PageMeta Content
Medicine / Merck / Rofecoxib / Sulfones / Ethics / Merck & Co. / Adverse effect / Joint and several liability / Negligence / Tort law / Law / COX-2 inhibitors


2004 S.H. No. IN THE SUPREME COURT OF NOVA SCOTIA
Add to Reading List

Document Date: 2014-06-20 15:01:54


Open Document

File Size: 279,42 KB

Share Result on Facebook

City

Digby / Mississauga / Halifax / Kirkland / /

Company

MERCK & CO. INC. / MERCK FROSST CANADA LTD. / Merck Ltd. / PLAINTIFF AND /

Country

United States / Canada / /

Currency

USD / /

Event

Product Issues / Product Recall / FDA Phase / /

Facility

Supreme Court / Whitehouse Station / SUPREME COURT OF NOVA SCOTIA BETWEEN / /

IndustryTerm

manufacturing / /

MedicalCondition

severe angina / severe chest pain / congestive heart failure / panic attacks / premature ventricular contraction / serious personal injuries / arthritis / deep venous thrombosis / cerebrovascular accident / stroke / transient ischemic attack / blood clots / pain / tachycardia / venous insufficiency / unstable angina / Heart attacks / angina pectoris / heart attack / bradycardia / acute migraine headaches / pulmonary embolism / atrial fibrillation / class members’ injuries / depression / injuries / /

MedicalTreatment

cardiac surgery / coronary bypass surgery / major surgery / /

Organization

CO. INC / SUPREME COURT / /

Person

Hugh F. Card / /

Position

pharmacist / physician / General / /

Product

VIOXX / drug / taking VIOXX / /

ProvinceOrState

New Jersey / Quebec / Nova Scotia / Ontario / /

SocialTag